Curanex Pharmaceuticals Inc
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| CURX | ACXP | CNSP | CTXR | 18H0.F | SNGX | |
|---|---|---|---|---|---|---|
| Market cap | 9.10M | 5.64M | 6.34M | 15.13M | 5.11M | 7.64M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | — | -0.6 | -11.1 | -0.4 | — | -1.4 |
| Price/book | 1.7 | 0.6 | 0.3 | 0.2 | -1.1 | 1.1 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −52.69% | −80.19% | −33.30% | −58.18% | −25.00% | −73.91% |
| Today | −6.30% | +0.98% | −4.62% | −3.87% | −23.81% | −1.49% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All CURX news ›Curanex Pharmaceuticals faces two securities class actions tied to August 2025 IPO
TradingView Curanex Pharmaceuticals faces two securities class actions tied to August 2025 IPO Curanex Pharmaceuticals is defending two putative securities class actions alleging misstatements and omissions in its Au
Curanex Pharmaceuticals - Securities Class Action Filed Against Curanex Pharmaceuticals And Underwriters On July 23, 2026 - SEC Filing
TradingView Curanex Pharmaceuticals - Securities Class Action Filed Against Curanex Pharmaceuticals And Underwriters On July 23, 2026 - SEC Filing
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- tradingview.com2
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.